[Retracted] Association between Oxidative Burden and Restenosis: A Case-Control Study

Table 2

Clinical characteristics of ISR and NISR groups.

Variables	ISR ()	NISR ()	value
Dyslipidemia %	71.4	46.2	0.081
Diabetics %	61.9	46.2	0.282
Hypertension %	71.4	65.4	0.659
Stent type %
Bare	50.0	11.1	0.015
Drug	50.0	88.9
Stent number %
1	66.7	65.4	0.927
>1	33.3	34.6
De novo stenosis in other vessels %	57.1	60.9	0.802
Duration of stent implantation (month)			0.200
Ejection fraction (%)			0.806
hs-CRP (mg/L)			0.509
Drugs consumption %
Statin	100.0	88.0	0.239
Aspirin	90.5	84.0	0.257
Clopidogrel	68.4	92.0	0.095
NSAID	15.0	4.0	0.197
β blocker	5.9	12.5	0.555
ARB	58.8	50.0
ACE inhibitor	29.4	12.5
CCB	5.9	18.8
Insulin	19.0	19.2	0.324
Oral diabetic drugs	38.1	19.2

Data are expressed as or percentage; statistically significant (). ISR: in-stent restenosis; NIRS: non-in-stent restenosis; hs-CRP: high-sensitivity C-reactive protein; ARB: angiotensin receptor blockers; ACE: angiotensin converting enzyme; CCB: channel calcium blocker; NSAID: nonsteroidal anti-inflammatory drugs.